Stay updated with breaking news from மேட் ஹார்ட்விக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA authorizes additional Johnson & Johnson batches from Baltimore facility baltimoresun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimoresun.com Daily Mail and Mail on Sunday newspapers.
Deal struck for Winnipeg facility to produce COVID-19 vaccine canada.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from canada.com Daily Mail and Mail on Sunday newspapers.
FDA allows troubled Baltimore COVID-19 vaccine factory to resume operations By Linda A. Johnson Why CDC recommends wearing masks indoors even if fully vaccinated The CDC updated guidance on masks, saying on July 27, 2021, that people in areas of high COVID-19 transmission should wear them indoors regardless of vaccination status. BALTIMORE (AP) - The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine, the company said Thursday. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of tens of millions of doses of vaccine it was making under contract for Johnson & Johnson. The bulk vaccine was contaminated with an ingredient for AstraZeneca’s COVID-19 vaccine, which was being made in the same factory. ....
•Reaffirms 2021 Full Year Forecast for Revenues and Profit GAITHERSBURG, Md., July 29, 2021-Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2021. Our second quarter performance demonstrates the strength of our strategy and diversified business model, said Robert G. Kramer, president and chief executive officer of Emergent BioSolutions. Through continued investment and innovation, we will play an important role in helping deliver solutions to the public health threats we face. We are proud to be resuming production of COVID-19 vaccine batches following additional reviews and collaboration with the Food and Drug Administration and our manufacturing partner. ....
ADVERTISEMENT FDA allows Emergent factory to resume vaccine work by LINDA A. JOHNSON THE ASSOCIATED PRESS | Today at 4:06 a.m. FILE - In this April 8, 2021 file photo, the Johnson & Johnson COVID-19 vaccine is seen at a pop up vaccination site in the Staten Island borough of New York. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine bulk substance to resume, the company said Thursday, July 29. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of tens of millions of doses of vaccine it was making under contract for Johnson & Johnson. (AP Photo/Mary Altaffer, File) ....